Actus Medical (AFIB) PT Lowered to $11 at Canaccord Genuity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AFIB Hot Sheet
Price: $0.00 --0%
Rating Summary:
2 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
2 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Canaccord Genuity analyst William Plovanic lowered the price target on Actus Medical (NASDAQ: AFIB) to $11.00 (from $16.00) while maintaining a Hold rating.
You May Also Be Interested In
- Camtek (CAMT) PT Lowered to $140 at Stifel
- Datadog (DDOG) PT Lowered to $285 at Rosenblatt
- Procore Technologies, Inc (PCOR) PT Raised to $85 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
